home / stock / bbi / bbi news


BBI News and Press, Brickell Biotech Inc. From 08/28/20

Stock Information

Company Name: Brickell Biotech Inc.
Stock Symbol: BBI
Market: NYSE

Menu

BBI BBI Quote BBI Short BBI News BBI Articles BBI Message Board
Get BBI Alerts

News, Short Squeeze, Breakout and More Instantly...

BBI - Are These Penny Stocks To Invest In Or Trade? 3 Biotech Names To Know

Are You Buying Or Investing In Penny Stocks Investing in penny stocks can be a risky game. When you really think about it, why do you invest, to begin with? Building wealth, assets, etc. Call it what you will but at the end of the day it boils down to 1 thing: money. Investing, trading, scal...

BBI - Brickell Biotech rallies; initiated BUY at Lake Street Capital

Lake Street Capital initiated Brickell Biotech ( BBI +17.2% ) with a Buy rating and price target of $6 indicating more than five-folds increase from current levels. More news on: Brickell Biotech, Inc., Stocks on the move, Healthcare stocks news, Read more ...

BBI - What Are The Best Penny Stocks To Buy? 4 Names To Know This Week

Will These Penny Stocks Be On Your List To Buy Or Avoid This Week? Are penny stocks part of your trading strategy right now? If you’re like millions of others using apps like WeBull, E-Trade Pro, or even Robinhood, penny stocks are probably an interest. Sure you can invest in blue-...

BBI - Brickell Biotech (BBI) Investor Presentation - Slideshow

The following slide deck was published by Brickell Biotech, Inc. in conjunction with this Read more ...

BBI - Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q2 2020 Results - Earnings Call Transcript

Brickell Biotech, Inc. (BBI) Q2 2020 Results Earnings Conference Call August 12, 2020, 04:30 PM ET Company Participants Daniel Ferry - Investor Relations, LifeSci Advisors Robert Brown - Chief Executive Officer Deepak Chadha - Chief R&D Officer Michael Carruthers - Chief Fi...

BBI - Brickell Biotech reports Q2 results

Brickell Biotech (NASDAQ: BBI ) : Q2 GAAP EPS of -$0.43. Revenue of $0.61M (-76.3% Y/Y) Press Release More news on: Brickell Biotech, Inc., Earnings news and commentary, Healthcare stocks news, ,

BBI - Brickell Biotech Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Positive data from the Sofpironium Bromide Phase 3 pivotal study in Japan presented in Q2 2020 by development partner, Kaken Kaken to receive regulatory decision in Japan for sofpironium bromide gel as early as the fourth quarter of 2020 Brickell plans to initiate its U.S. pivotal...

BBI - Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020

BOULDER, Colo., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today ann...

BBI - INO, PEI among premarket gainers

Fuwei Films (NASDAQ: FFHL ) +66%  on Q1 results . More news on: Fuwei Films (Holdings) Co., Ltd., Translate Bio, Inc., Recon Technology, Ltd., Stocks on the move, , Read more ...

BBI - NES, ISEE, QUIK and BBI among midday movers

Gainers:  Alpine Immune Sciences (NASDAQ: ALPN )  +174% . More news on: Alpine Immune Sciences, Inc., Aethlon Medical, Inc., Urban One, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10